DK2349228T3 - IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCEDURE FOR THEIR MANUFACTURING - Google Patents
IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCEDURE FOR THEIR MANUFACTURING Download PDFInfo
- Publication number
- DK2349228T3 DK2349228T3 DK09783831.2T DK09783831T DK2349228T3 DK 2349228 T3 DK2349228 T3 DK 2349228T3 DK 09783831 T DK09783831 T DK 09783831T DK 2349228 T3 DK2349228 T3 DK 2349228T3
- Authority
- DK
- Denmark
- Prior art keywords
- iron
- capsules
- alginate
- salt
- water
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 452
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 225
- 239000002775 capsule Substances 0.000 title claims abstract description 221
- 238000000034 method Methods 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 title abstract description 14
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 59
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 45
- 229920000615 alginic acid Polymers 0.000 claims abstract description 45
- 150000002505 iron Chemical class 0.000 claims abstract description 41
- 229940072056 alginate Drugs 0.000 claims abstract description 35
- 239000007787 solid Substances 0.000 claims abstract description 25
- 235000010410 calcium alginate Nutrition 0.000 claims abstract description 12
- 239000000648 calcium alginate Substances 0.000 claims abstract description 12
- 229960002681 calcium alginate Drugs 0.000 claims abstract description 12
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 235000013618 yogurt Nutrition 0.000 claims description 41
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical group CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 32
- 235000010413 sodium alginate Nutrition 0.000 claims description 32
- 239000000661 sodium alginate Substances 0.000 claims description 32
- 229940005550 sodium alginate Drugs 0.000 claims description 32
- 235000013336 milk Nutrition 0.000 claims description 29
- 210000004080 milk Anatomy 0.000 claims description 29
- 239000011788 ferric saccharate Substances 0.000 claims description 27
- 235000008824 ferric saccharate Nutrition 0.000 claims description 27
- XRDYWGSODBNAIE-BQGRAUOOSA-K iron(3+);(2r,3s,4s,5s)-2,3,4,5,6-pentahydroxy-6-oxohexanoate Chemical group [Fe+3].OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O XRDYWGSODBNAIE-BQGRAUOOSA-K 0.000 claims description 27
- 239000008267 milk Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 18
- 241000282414 Homo sapiens Species 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 235000013372 meat Nutrition 0.000 claims description 12
- 235000013580 sausages Nutrition 0.000 claims description 11
- 206010022971 Iron Deficiencies Diseases 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 159000000007 calcium salts Chemical class 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 68
- 238000003860 storage Methods 0.000 abstract description 24
- 238000011068 loading method Methods 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 description 49
- 229910052791 calcium Inorganic materials 0.000 description 43
- 239000003094 microcapsule Substances 0.000 description 43
- 239000000047 product Substances 0.000 description 38
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 35
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 32
- 241001465754 Metazoa Species 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000002245 particle Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 19
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 17
- 235000011148 calcium chloride Nutrition 0.000 description 17
- 239000000725 suspension Substances 0.000 description 17
- 239000001110 calcium chloride Substances 0.000 description 16
- 229910001628 calcium chloride Inorganic materials 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- 239000003925 fat Substances 0.000 description 15
- 230000003647 oxidation Effects 0.000 description 14
- 238000007254 oxidation reaction Methods 0.000 description 14
- 239000011790 ferrous sulphate Substances 0.000 description 13
- 235000003891 ferrous sulphate Nutrition 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 208000007502 anemia Diseases 0.000 description 12
- -1 iron cation Chemical class 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 235000014590 basal diet Nutrition 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 229960001126 alginic acid Drugs 0.000 description 9
- 239000000783 alginic acid Substances 0.000 description 9
- 150000004781 alginic acids Chemical class 0.000 description 9
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 9
- 150000002739 metals Chemical class 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000013642 negative control Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 239000002738 chelating agent Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 7
- 159000000014 iron salts Chemical class 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000000265 homogenisation Methods 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000011773 ferrous fumarate Substances 0.000 description 5
- 235000002332 ferrous fumarate Nutrition 0.000 description 5
- 229960000225 ferrous fumarate Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 208000025371 Taste disease Diseases 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 description 4
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000013681 dietary sucrose Nutrition 0.000 description 4
- 229960001604 ferrous succinate Drugs 0.000 description 4
- 235000014106 fortified food Nutrition 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 150000001457 metallic cations Chemical class 0.000 description 4
- 235000019656 metallic taste Nutrition 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000001639 calcium acetate Substances 0.000 description 3
- 235000011092 calcium acetate Nutrition 0.000 description 3
- 229960005147 calcium acetate Drugs 0.000 description 3
- 239000004490 capsule suspension Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000004222 ferrous gluconate Substances 0.000 description 3
- 235000013924 ferrous gluconate Nutrition 0.000 description 3
- 229960001645 ferrous gluconate Drugs 0.000 description 3
- 239000004225 ferrous lactate Substances 0.000 description 3
- 235000013925 ferrous lactate Nutrition 0.000 description 3
- 229940037907 ferrous lactate Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000004313 iron ammonium citrate Substances 0.000 description 3
- 235000000011 iron ammonium citrate Nutrition 0.000 description 3
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 208000027219 Deficiency disease Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000000184 acid digestion Methods 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000010407 ammonium alginate Nutrition 0.000 description 2
- 239000000728 ammonium alginate Substances 0.000 description 2
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000020189 fortified milk Nutrition 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 244000144993 groups of animals Species 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002506 iron compounds Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- 229910015449 FeCU Inorganic materials 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 241000288147 Meleagris gallopavo Species 0.000 description 1
- 102100021867 Natural resistance-associated macrophage protein 2 Human genes 0.000 description 1
- 101710171645 Natural resistance-associated macrophage protein 2 Proteins 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000559 atomic spectroscopy Methods 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004887 ferric hydroxide Drugs 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical group [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 231100000628 reference dose Toxicity 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000014122 turkey meat Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Dairy Products (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08166052A EP2174657A1 (en) | 2008-10-08 | 2008-10-08 | Iron source product in the form of capsules and process for their prepartion |
| US11426108P | 2008-11-13 | 2008-11-13 | |
| PCT/EP2009/063059 WO2010040789A1 (en) | 2008-10-08 | 2009-10-07 | Iron source product in the form of capsules and process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2349228T3 true DK2349228T3 (en) | 2018-02-26 |
Family
ID=40303748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09783831.2T DK2349228T3 (en) | 2008-10-08 | 2009-10-07 | IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCEDURE FOR THEIR MANUFACTURING |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20110195147A1 (enExample) |
| EP (2) | EP2174657A1 (enExample) |
| JP (1) | JP5757528B2 (enExample) |
| KR (1) | KR20110075008A (enExample) |
| CN (1) | CN102176903B (enExample) |
| AR (1) | AR073415A1 (enExample) |
| BR (1) | BRPI0920228B1 (enExample) |
| CA (1) | CA2737401C (enExample) |
| CL (1) | CL2011000616A1 (enExample) |
| CO (1) | CO6361909A2 (enExample) |
| CY (1) | CY1119915T1 (enExample) |
| DK (1) | DK2349228T3 (enExample) |
| EC (1) | ECSP11010939A (enExample) |
| ES (1) | ES2662649T3 (enExample) |
| HR (1) | HRP20180144T1 (enExample) |
| HU (1) | HUE038130T2 (enExample) |
| LT (1) | LT2349228T (enExample) |
| MX (1) | MX2011003750A (enExample) |
| NO (1) | NO2349228T3 (enExample) |
| PE (1) | PE20110389A1 (enExample) |
| PL (1) | PL2349228T3 (enExample) |
| PT (1) | PT2349228T (enExample) |
| RU (1) | RU2491059C2 (enExample) |
| SI (1) | SI2349228T1 (enExample) |
| SM (1) | SMT201800132T1 (enExample) |
| UA (1) | UA104436C2 (enExample) |
| WO (1) | WO2010040789A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102589963B (zh) * | 2011-12-22 | 2013-11-27 | 攀钢集团攀枝花钢铁研究院有限公司 | 一种钛精矿、钛渣或碳化钛渣的消解方法和检测方法 |
| CN102940037B (zh) * | 2012-05-23 | 2014-06-04 | 四川农业大学 | 制备共沉淀氢氧化铁酸奶的方法 |
| ES2729839T3 (es) | 2012-06-01 | 2019-11-06 | Dsm Ip Assets Bv | Suplementación con minerales de bebidas |
| CN105377059A (zh) * | 2013-07-05 | 2016-03-02 | 雀巢产品技术援助有限公司 | 乳铁蛋白-骨桥蛋白-铁络合物 |
| RU2548777C2 (ru) * | 2013-07-09 | 2015-04-20 | Александр Александрович Кролевец | Способ получения частиц инкапсулированных жирорастворимой полимерной оболочкой солей металлов, обладающих супрамолекулярными свойствами |
| EP3086654A1 (en) * | 2013-12-27 | 2016-11-02 | Nestec S.A. | Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste |
| US10863753B2 (en) | 2015-10-01 | 2020-12-15 | The Governing Council Of The University Of Toronto | Iron-fortified tea preparations and methods of making same |
| RU2623593C1 (ru) * | 2016-02-10 | 2017-06-28 | Александр Александрович Кролевец | Способ получения мармелада с повышенным содержанием железа |
| WO2020172623A1 (en) | 2019-02-21 | 2020-08-27 | Ingenuity Foods, Inc. | Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products |
| IT201900025393A1 (it) | 2019-12-23 | 2021-06-23 | Pharma Line S R L | Formulazione microincapsulata comprendente ferro e cistina, sue composizioni e loro uso per il trattamento di anemia o una deficienza di ferro |
| CN111493257A (zh) * | 2020-04-27 | 2020-08-07 | 郑州瑞普生物工程有限公司 | 一种蛋白固体饮料及其制备方法 |
| US11776118B2 (en) * | 2020-12-02 | 2023-10-03 | International Business Machines Corporation | Recognition of partially digested medications |
| GB2617580B (en) * | 2022-04-12 | 2024-05-22 | Foster & Freeman Ltd | Latent fingermark validation strips |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3228231A1 (de) * | 1982-07-28 | 1984-02-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung |
| JPH03285654A (ja) * | 1990-03-30 | 1991-12-16 | Snow Brand Milk Prod Co Ltd | 機能性物質を高濃度に内包したカプセル体及びその製造法 |
| US20030190355A1 (en) * | 2002-04-05 | 2003-10-09 | Hermelin Marc S. | Modified release minerals |
| GB0310673D0 (en) * | 2003-05-09 | 2003-06-11 | Givaudan Sa | Alginate matrix particles |
| BR0305871B1 (pt) | 2003-11-24 | 2014-10-21 | Inst Pesquisas Tech | Produto à base de sulfato ferroso para fortificação de alimentos desidratados e método de preparação |
| RU2287302C2 (ru) * | 2004-05-13 | 2006-11-20 | Федеральное Государственное образовательное учреждение Высшего профессионального образования Вологодская государственная молочнохозяйственная академия им. Н.В. Верещагина | Способ обогащения минеральными веществами пищевого продукта |
| EP1743530B1 (en) * | 2005-07-15 | 2011-08-31 | Unilever N.V. | Iron fortified food product and additive |
| BRPI0716157A2 (pt) * | 2006-09-05 | 2013-09-17 | Ct Brasileiro De Pesquisa Fisica Cbpf | processo para produÇço microcÁpsulas dotadas de propriedades magnÉticas, produto obtido e mÉtodo para a liberaÇço controlada de substÂncias ativas |
-
2008
- 2008-10-08 EP EP08166052A patent/EP2174657A1/en not_active Withdrawn
-
2009
- 2009-07-10 UA UAA201105366A patent/UA104436C2/uk unknown
- 2009-09-30 AR ARP090103795A patent/AR073415A1/es unknown
- 2009-10-07 BR BRPI0920228-5A patent/BRPI0920228B1/pt active IP Right Grant
- 2009-10-07 PT PT97838312T patent/PT2349228T/pt unknown
- 2009-10-07 NO NO09783831A patent/NO2349228T3/no unknown
- 2009-10-07 RU RU2011118360/15A patent/RU2491059C2/ru active
- 2009-10-07 EP EP09783831.2A patent/EP2349228B8/en active Active
- 2009-10-07 DK DK09783831.2T patent/DK2349228T3/en active
- 2009-10-07 US US13/123,222 patent/US20110195147A1/en not_active Abandoned
- 2009-10-07 CN CN2009801395373A patent/CN102176903B/zh active Active
- 2009-10-07 HU HUE09783831A patent/HUE038130T2/hu unknown
- 2009-10-07 WO PCT/EP2009/063059 patent/WO2010040789A1/en not_active Ceased
- 2009-10-07 JP JP2011530484A patent/JP5757528B2/ja active Active
- 2009-10-07 PE PE2011000837A patent/PE20110389A1/es not_active Application Discontinuation
- 2009-10-07 SM SM20180132T patent/SMT201800132T1/it unknown
- 2009-10-07 CA CA2737401A patent/CA2737401C/en not_active Expired - Fee Related
- 2009-10-07 MX MX2011003750A patent/MX2011003750A/es active IP Right Grant
- 2009-10-07 HR HRP20180144TT patent/HRP20180144T1/hr unknown
- 2009-10-07 LT LTEP09783831.2T patent/LT2349228T/lt unknown
- 2009-10-07 KR KR1020117010346A patent/KR20110075008A/ko not_active Ceased
- 2009-10-07 ES ES09783831.2T patent/ES2662649T3/es active Active
- 2009-10-07 PL PL09783831T patent/PL2349228T3/pl unknown
- 2009-10-07 SI SI200931808T patent/SI2349228T1/en unknown
-
2011
- 2011-03-23 CL CL2011000616A patent/CL2011000616A1/es unknown
- 2011-03-29 CO CO11038415A patent/CO6361909A2/es active IP Right Grant
- 2011-04-01 EC EC2011010939A patent/ECSP11010939A/es unknown
-
2018
- 2018-02-14 CY CY20181100178T patent/CY1119915T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2349228T3 (en) | IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCEDURE FOR THEIR MANUFACTURING | |
| Ariyarathna et al. | The rise of inorganic nanomaterial implementation in food applications | |
| Ghibaudo et al. | Pectin-iron capsules: Novel system to stabilise and deliver lactic acid bacteria | |
| EP3585805B1 (en) | Composite materials comprising amyloid fibrils and nanoparticulate nutritional minerals | |
| Dehnad et al. | Recent advances in iron encapsulation and its application in food fortification | |
| Mnisi et al. | Bioaccessibility and risk assessment of essential and non-essential elements in vegetables commonly consumed in Swaziland | |
| Wang et al. | Double enzymatic hydrolysis preparation of heme from goose blood and microencapsulation to promote its stability and absorption | |
| Muñoz-More et al. | Microencapsulated iron in food, techniques, coating material, efficiency, and sensory analysis: a review | |
| Tan et al. | Influence of different nano/micro-carriers on the bioavailability of iron: Focus on in vitro–in vivo studies | |
| WO2000051446A1 (en) | Ferric fortification for foods and drinks | |
| WO2006114840A1 (ja) | 乳蛋白質を含有する鉄組成物 | |
| Leiva Arrieta | Double (iron and zinc) fortified black tea: assessing the bioaccessibility and bioavailability using spray drying microencapsulation technology | |
| Altemimi et al. | Application of Nanoparticles in Human Nutrition: A Review. Nutrients 2024, 16, 636 | |
| Siddiqui et al. | Spray encapsulation of iron in chitosan biopolymer for tea fortification | |
| Rajendran et al. | Metallic nanoparticles in the food industry: Advantages and limitations | |
| Saeidy et al. | Physicochemical properties of calcium-fortified soymilk with microencapsulated and chelated calcium salt | |
| Gulmez et al. | Spray Drying Encapsulation of Minerals | |
| US12290091B2 (en) | Composite materials comprising amyloid fibrils and nanoparticulate nutritional minerals | |
| Oyewole | Hibiscus sabdariffa Calyces as the Basis of a Beverage to Combat Iron Deficiency in Sub-Saharan Africa | |
| Gupta | Development and evaluation of microencapsulated iron fortified yoghurt | |
| STATION | MICROENCAPSULATED ZINC POWDER: PREPARATION, ENGINEERING PROPERTIES AND FORTIFICATION OF MILK | |
| CN120092933A (zh) | 一种含有益生菌的芝麻丸的制备方法 | |
| Turp et al. | Health Benefits of Fish Oil and the Application of Encapsulated Fish Oil in Meat and Dairy Products | |
| Rajendran et al. | Metallic Nanoparticles in the Food Industry | |
| Rodrigues Ferreira et al. | Iron-Loaded Microcapsules Produced by Complex Coacervation: A Promising Strategy for Food Fortification |